SIGA Technologies, Inc. (SIGA)
NASDAQ: SIGA · Real-Time Price · USD
6.67
-0.49 (-6.78%)
Dec 3, 2024, 2:13 PM EST - Market open
Company Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States.
Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus.
The company was incorporated in 1995 and is headquartered in New York, New York.
SIGA Technologies, Inc.
| Country | United States |
| Founded | 1995 |
| IPO Date | Sep 9, 1997 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 45 |
| CEO | Diem Nguyen |
Contact Details
Address: 31 East 62nd Street New York, New York 10065 United States | |
| Phone | 212 672 9100 |
| Website | siga.com |
Stock Details
| Ticker Symbol | SIGA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001010086 |
| CUSIP Number | 826917106 |
| ISIN Number | US8269171067 |
| Employer ID | 13-3864870 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Diem Nguyen M.B.A., Ph.D. | Chief Executive Officer and Director |
| Daniel J. Luckshire CPA | Executive Vice President, Chief Financial Officer and Secretary |
| Dr. Dennis E. Hruby Ph.D. | Executive Vice President and Chief Scientific Officer |
| Tove C. Bolken | Senior Vice President of Operations and Chief Supply Chain Officer |
| Herb Vloedman | Senior Vice President and Chief Information Officer |
| Lawrence R. Miller Esq., J.D. | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | 10-Q | Quarterly Report |
| Nov 7, 2024 | 8-K | Current Report |
| Oct 24, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Oct 4, 2024 | 8-K | Current Report |
| Sep 23, 2024 | 8-K | Current Report |
| Sep 20, 2024 | 8-K | Current Report |
| Aug 15, 2024 | 8-K | Current Report |
| Aug 1, 2024 | 10-Q | Quarterly Report |
| Aug 1, 2024 | 8-K | Current Report |